These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32945506)

  • 21. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells.
    Lindsay C; Kostiuk M; Conrad D; O'Connell DA; Harris J; Seikaly H; Biron VL
    Mol Carcinog; 2019 Nov; 58(11):1946-1959. PubMed ID: 31338907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers.
    Reid P; Staudacher AH; Marcu LG; Olver I; Moghaddasi L; Brown MP; Bezak E
    Sci Rep; 2020 Feb; 10(1):2716. PubMed ID: 32066820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
    Dalianis T
    Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of p16
    Wagner S; Prigge ES; Wuerdemann N; Reder H; Bushnak A; Sharma SJ; Obermueller T; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Wolf G; Pons-Kühnemann J; Wittekindt C; Klussmann JP
    Br J Cancer; 2020 Sep; 123(7):1114-1122. PubMed ID: 32624580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region.
    Ren J; Yang W; Su J; Ren X; Fazelzad R; Albert T; Habbous S; Goldstein DP; de Almeida JR; Hansen A; Jang R; Bratman SV; Hope A; Chen R; Wang J; Xu Y; Cheng D; Zhao Y; Xu W; Liu G
    Int J Cancer; 2019 Sep; 145(6):1465-1474. PubMed ID: 30698281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.
    Yakin M; Seo B; Hussaini H; Rich A; Hunter K
    Aust Dent J; 2019 Mar; 64(1):11-18. PubMed ID: 30238467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.
    Rietbergen MM; Martens-de Kemp SR; Bloemena E; Witte BI; Brink A; Baatenburg de Jong RJ; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Eur J Cancer; 2014 Mar; 50(4):765-73. PubMed ID: 24315751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer.
    White R; Abel S; Hasan S; Verma V; Greenberg L; Colonias A; Wegner RE
    Laryngoscope; 2020 Apr; 130(4):E171-E176. PubMed ID: 31120601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
    Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status.
    Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
    Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Faden DL; Kuhs KAL; Lin M; Langenbucher A; Pinheiro M; Yeager M; Cullen M; Boland JF; Steinberg M; Bass S; Lewis JS; Lawrence MS; Ferris RL; Mirabello L
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma.
    De Felice F; Musio D; Abate G; Moscarelli E; Bulzonetti N; Tombolini V
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):477-483. PubMed ID: 31686249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.